Your session is about to expire
Glucotrol vs Amaryl
Introduction
For patients with type 2 diabetes, certain medications that help control blood sugar levels can be crucial in managing the disease and its symptoms. Glucotrol (glipizide) and Amaryl (glimepiride) are two such drugs frequently prescribed to treat type 2 diabetes. Both belong to a class of medication called sulfonylureas which work by stimulating the release of insulin from beta cells in the pancreas. This release helps lower blood glucose levels, assisting individuals in maintaining their diabetic condition under control.
Glucotrol is known for being fast-acting but short-lasting, making it suitable for controlling post-meal spikes in blood sugar. On the other hand, Amaryl has a slower onset but longer lasting effect making it more appropriate for maintaining consistent blood glucose levels throughout the day. It's important to note both these medications may cause hypoglycemia (low blood sugar), so they should be used with caution.
Glucotrol vs Amaryl Side By Side
| Attribute | Glucotrol | Amaryl |
|---|---|---|
| Brand Name | Glucotrol | Amaryl |
| Contraindications | Should not be taken with miconazole due to increased risk of hypoglycemia. Use with caution in patients with liver disease. | Should not be taken with miconazole due to increased risk of hypoglycemia. Use with caution in patients with liver disease. |
| Cost | For brand name: around $75 for 60 tablets of Glucotrol XL (5 mg). For generic: approximately $0.13 to $0.45 per day. | For brand name: about $100 for 30 tablets of Amaryl (2 mg). For generic: starting as low as approximately $0.09 per day. |
| Generic Name | glipizide | glimepiride |
| Most Serious Side Effect | Signs of allergic reaction, low blood sugar symptoms, symptoms related to liver problems, unusual bleeding or bruising, mental/mood changes, severe gastrointestinal issues. | Signs of an allergic reaction, difficulty breathing or swelling in your face or throat, symptoms of low blood sugar, rapid heartbeat and feelings of anxiety, skin pain with redness followed by a blistering rash. |
| Severe Drug Interactions | Miconazole | Miconazole |
| Typical Dose | 5-40 mg/day, starting dose usually 5 mg | 1–2 mg/day, up to a maximum of 8 mg/day |
What is Glucotrol?
Glipizide (the generic name for Glucotrol) was one of the first drugs in the sulfonylurea class of antidiabetic medications, which represented a significant progress over earlier classes of diabetes treatments. It was first approved by the FDA in 1984. Glucotrol works by stimulating pancreatic beta cells to increase insulin production, effectively enhancing glucose uptake and utilization, thus controlling blood sugar levels more efficiently. It is primarily prescribed for managing type 2 diabetes when diet and exercise are not sufficient.
On the other hand, glimepiride (the generic name for Amaryl) is also a part of sulfonylurea drug class but it’s considered as second-generation medication due to its longer duration of action and far lower risk of hypoglycemia than earlier compounds like glipizide. Both have similar effectiveness at lowering blood sugar but Amaryl has somewhat less side effects relating to weight gain compared with other sulfonylureas.
What conditions is Glucotrol approved to treat?
Glucotrol (glipizide) and Amaryl (glimepiride) are both approved for the treatment of type 2 diabetes mellitus:
- They are used as adjuncts to diet and exercise to improve glycemic control in adults with type 2 diabetes.
- Both may be used in combination with other antidiabetic medications if needed.
How does Glucotrol help with these illnesses?
Glucotrol (glipizide) and Amaryl (glimepiride) are both oral medications that help to manage type 2 diabetes by increasing the amount of insulin released from the pancreas. Insulin is a hormone that helps regulate blood sugar levels in the body, allowing cells to use and store sugar for energy. In individuals with type 2 diabetes, there's either an inadequate response to insulin or not enough insulin being produced, leading to high blood glucose levels. Both Glucotrol and Amaryl work by stimulating pancreatic beta cells to secrete more insulin, thus aiding in maintaining healthy blood sugar levels throughout the day. However, it should be noted that while they have similar effects on managing diabetes symptoms, they may differ in terms of dosing frequency and side effects profile which could play a role when choosing between these two drugs.
What is Amaryl?
Amaryl, whose generic name is glimepiride, is a long-acting sulfonylurea that works by stimulating the beta cells of the pancreas to release more insulin. This increased production of insulin helps lower blood sugar levels in individuals with type 2 diabetes. Amaryl was first approved by the FDA in 1995.
Unlike Glucotrol (glipizide), which also belongs to the class of sulfonylureas but has a shorter duration of action, Amaryl only needs to be taken once daily due to its extended-release properties. Also, compared to Glucotrol, it's generally associated with fewer gastrointestinal side effects and less hypoglycemia (low blood sugar).
However, common side effects can include dizziness and weight gain among others; these are similar across all sulfonylureas including Glucotrol and other medicines such as Prozac. The ability for Amaryl to stimulate greater insulin production may make it an effective choice for those patients who aren't responding adequately to other oral antidiabetic drugs.
What conditions is Amaryl approved to treat?
Amaryl, also known as glimepiride, is a medication that has been approved by the FDA for the treatment of:
- Type 2 diabetes mellitus This medication aids in managing and controlling blood sugar levels in patients who can't control these levels through diet and exercise alone. It's important to note that Amaryl is usually used alongside a proper diet and regular exercise regimen to achieve optimal results.
How does Amaryl help with these illnesses?
Amaryl, like Glucotrol, is a medication that helps manage blood sugar levels in individuals with type 2 diabetes. It works by stimulating the release of insulin from beta cells in the pancreas which aids in lowering blood glucose. Amaryl also makes your body's cells more sensitive to insulin so it can work more effectively. This mitigates the risk of hyperglycemia and its associated complications such as kidney damage or heart disease. While similar to Glucotrol, Amaryl has a longer duration of action which allows it to maintain stable blood glucose levels throughout the day better than Glucotrol for some patients. Given these characteristics, Amaryl could be an appropriate choice when patients do not respond adequately to other sulfonylureas like Glucotrol.
How effective are both Glucotrol and Amaryl?
Both glipizide (Glucotrol) and glimepiride (Amaryl) have established histories of success in treating patients with type 2 diabetes, and they were approved by the FDA about a decade apart. Since they act on different potassium channels, they may be prescribed under different circumstances. The effectiveness of Glucotrol and Amaryl in controlling blood sugar levels was directly studied in several clinical trials; the two drugs exhibited similar efficacy in managing symptoms of hyperglycemia as well as comparable safety profiles. In these studies, none of the metrics used to measure efficacy in controlling blood sugar differed significantly between patients receiving Glucotrol and those receiving Amaryl.
A review published in 2003 found that glimepiride is effective at reducing HbA1c levels starting from the first week of treatment, its side effect profile is favorable over many other sulfonylureas, and it is well-tolerated even among elderly populations. This study reports that Amaryl has become one of the most widely-prescribed antidiabetic medications worldwide due to its once-daily dosing regimen.
On another note, a meta-analysis conducted in 2013 indicated that Glucotrol seems more effective than placebo at lowering fasting plasma glucose levels but appears to be similar in efficacy to other common sulfonylureas. Nonetheless, Glucotrol is often considered only after metformin or lifestyle modifications have failed to control glucose levels effectively. Significant research on its use involves co-prescription alongside metformin or insulin therapy so data confirming its efficacy as a stand-alone treatment are less robust than for Amaryl.
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Glucotrol typically prescribed?
Oral dosages of Glucotrol range from 5-40 mg/day, but studies have indicated that an initial daily dose of 5 mg Glucotrol is sufficient for treating type 2 diabetes in most people. Children under the age of 18 are typically not given this medication. In adults, dosage can be increased after a few weeks if there is no response. The maximum dosage that should not be exceeded per day is generally 40mg.
On the other hand, oral dosages of Amaryl range from 1–8 mg/day and it's recommended to start with a low dose (1 or 2mg) to minimize the risk of hypoglycaemia. Just as with Glucotrol, children aren't usually prescribed this medication either. Dosage can also be increased after a few weeks if there isn't sufficient control over blood sugar levels but exceeding a maximum dosage of 8mg per day isn't advisable.
At what dose is Amaryl typically prescribed?
Treatment with Amaryl typically commences at a dosage of 1–2 mg/day. If required, this initial dose can be gradually increased to a maximum of 8 mg/day, divided into two doses that are spaced 12 hours apart. For patients whose blood sugar levels remain high after several weeks on the initial treatment plan, the daily dosage may then be further increased to a maximum of 16 mg per day, divided into two separate doses. This is contingent upon careful monitoring and regular consultation with your healthcare provider.
What are the most common side effects for Glucotrol?
Side effects of Glucotrol and Amaryl can vary in severity, but the common ones include:
- Hypoglycemia (low blood sugar) which may manifest as anxiety, nervousness or tremors
- Nausea and/or vomiting
- Diarrhea or constipation
- Dizziness, weakness or fatigue
- Headache
- Skin rash, itching or redness
- Weight gain These medications do not commonly cause insomnia, dry mouth, decreased libido, abnormal ejaculation or impotence. However if you experience any unusual symptoms while taking these drugs it is important to consult your healthcare provider immediately.
Are there any potential serious side effects for Glucotrol?
While Glucotrol (glipizide) and Amaryl (glimepiride) are both oral medications used to control blood sugar levels in individuals with type 2 diabetes, they may produce different side effects. Some severe, but rare potential side effects could include:
- Signs of allergic reaction: hives; difficulty breathing or swallowing; swelling of the face, lips or throat
- Low blood sugar symptoms: sudden sweating, shaking, fast heartbeat, hunger, blurred vision, dizziness or tingling hands/feet.
- Symptoms related to liver problems: yellowing eyes/skin; dark urine; persistent nausea/vomiting/stomach pain.
- Unusual bleeding or bruising
- Mental/mood changes
- Severe gastrointestinal issues like persistent diarrhea or vomiting
In case of experiencing any signs of these serious side effects while taking either medication - Glucotrol or Amaryl - it is crucial that you seek immediate medical attention.
What are the most common side effects for Amaryl?
When considering Amaryl, here are some possible side effects to be aware of:
- Nausea, stomach pain or upset
- Dizziness, headache
- Mild skin rash or redness
- Weight gain
- Pale skin, easy bruising or bleeding
- Symptoms of low blood sugar (hypoglycemia) like sudden sweating, shaking, fast heartbeat, hunger etc.
- Changes in your vision.
As with any medication decision you make with your healthcare provider it's important to weigh the potential benefits against these possible side effects.
Are there any potential serious side effects for Amaryl?
While Amaryl is generally well-tolerated, it can cause more serious side effects in some individuals. If you notice any of the following symptoms after using Amaryl, seek medical attention immediately:
- Signs of an allergic reaction such as hives, itching or skin rash. Severe reactions may be accompanied by fever and swollen glands.
- Difficulty breathing or swelling in your face or throat which might indicate severe hypersensitivity.
- Symptoms of low blood sugar such as confusion, unusual changes in mood or behavior, blurred vision, dizziness, sweating profusely without exertion or feeling shaky; these could result from the medication's intended effect on insulin levels going too far.
- Rapid heartbeat and feelings of anxiety could hint at cardiovascular stress caused by your body reacting to low glucose levels.
- Skin pain with redness followed by a blistering rash; this could be a sign of Stevens-Johnson Syndrome which requires immediate medical care.
If you experience any severe adverse effects while taking Amaryl (glimepiride), contact your doctor right away.
Contraindications for Glucotrol and Amaryl?
Glucotrol and Amaryl, like other antidiabetic medications, may cause hypoglycemia (low blood sugar) in some people. If you notice symptoms of hypoglycemia such as rapid heartbeat, sweating, or blurred vision after taking these medications, please seek immediate medical attention.
Neither Glucotrol nor Amaryl should be taken if you are using miconazole (an antifungal medication), since this can enhance the blood glucose-lowering effect of these drugs and increase your risk for hypoglycemia. Always inform your healthcare provider about all the medications you are currently taking; miconazole will require a period of about 1 to 2 weeks to clear from your body before starting with Glucotrol or Amaryl to prevent dangerous interactions.
Furthermore, both Glucotrol and Amaryl should be used with caution in patients with liver disease as they might affect liver function tests. Also remember that lifestyle modifications such as healthy dieting and regular exercise play an important role in managing diabetes along with medication therapy.
How much do Glucotrol and Amaryl cost?
For the brand name versions of these drugs:
- The price for 60 tablets of Glucotrol XL (5 mg) averages around $75, which works out to approximately $1.25/day.
- The cost for 30 tablets of Amaryl (2 mg) is about $100, working out to be roughly $3.33/day.
Thus, if you are prescribed a high dose range for Glucotrol XL (i.e., 10 mg/day or higher), then brand-name Amaryl can become less expensive on a per-day treatment basis. However, it's important to note that cost should not be the primary consideration in determining which drug best suits your needs.
For generic versions of Glucotrol XL (glipizide) and Amaryl (glimepiride):
-
Generic glipizide is available in packs from 30 up to 90 tablets with approximate costs ranging between $0.13 and $0.45 per day based on dosages from 5mg up to even 20mg.
-
Generic glimepiride has similar pack sizes as glipizide with daily costs starting as low as approximately $.09/per day and going up depending upon dosage size.
These prices may differ based on location and pharmacy but signify that generics tend to offer significantly lower costs compared to their branded counterparts.
Popularity of Glucotrol and Amaryl
Glipizide, known by its brand name Glucotrol, was prescribed to an estimated 7.4 million people in the US in 2020. It's one of the most commonly used oral medications for managing type 2 diabetes, accounting for roughly 15% of sulfonylurea prescriptions (a class of diabetes medication) in the United States.
In contrast, glimepiride (brand name Amaryl), another member of the sulfonylureas family used to control high blood sugar in people with type 2 diabetes, was prescribed to approximately 3.9 million individuals across America over that same year. This represents just under 8% of all sulfonylurea prescriptions and has shown a relatively consistent usage rate over recent years.
Both these drugs stimulate pancreatic beta cells to release insulin which helps lower blood glucose levels. However, they vary slightly with respect to their side effect profiles and dosing schedules.
Conclusion
Both Glucotrol (glipizide) and Amaryl (glimepiride) have extensive histories of use in managing type 2 diabetes, with an abundance of clinical studies supporting their efficacy over placebo treatments. Both drugs belong to the sulfonylurea class and primarily work by stimulating pancreatic beta cells to release more insulin. However, they may be used together under certain circumstances, but this requires thorough evaluation by a physician as potential drug interactions need to be considered.
While both glipizide and glimepiride are first-line treatment options for type 2 diabetes management, they tend to be prescribed under different conditions. For example, Glucotrol is often preferred in patients with kidney disease due its shorter half-life compared to Amaryl.
Both medications are available as affordable generics which can significantly reduce costs for patients who must pay out-of-pocket expenses. Like most anti-diabetic drugs, both Glucotrol and Amaryl might require some time before desired glucose control is achieved.
The overall side effect profiles of these two agents are similar; however, glimepiride has a slightly lower risk of hypoglycemia than does glipizide. Common side effects include low blood sugar levels (hypoglycemia), upset stomach or heartburn, skin rash or itching and weight gain among others. Patients should monitor their blood glucose closely during therapy initiation and adjustment periods especially if there's any significant change in meal patterns or physical activities.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Luis Bautista, J., Bugos, C., Dirnberger, G., & Atherton, T. (2003, January). Efficacy and safety profile of glimepiride in Mexican American Patients with type 2 diabetes mellitus: A randomized, placebo-controlled study. Clinical Therapeutics. Elsevier BV.http://doi.org/10.1016/s0149-2918(03)90025-7
- Hermansen, K., Kipnes, M., Luo, E., Fanurik, D., Khatami, H., Stein, P., & Sitagliptin Study 035 Group. (2007, June 26). Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin. Diabetes, Obesity and Metabolism. Wiley.http://doi.org/10.1111/j.1463-1326.2007.00744.x